GW&K Investment Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$16.7M Sell
2025
Q2
$23.5M Sell
2025
Q1
$21.6M Sell
2024
Q4
$22.1M Sell
2024
Q3
$24.9M Sell
2024
Q2
$21M Sell
2024
Q1
$17.5M Buy
2023
Q4
$14M Sell
2023
Q3
$18.2M Sell
2023
Q2
$18.3M Sell
2023
Q1
$21.7M Buy
2022
Q4
$19.8M Buy
2022
Q3
$17.9M Buy